Vigilant Biosciences® Logo

Transform Your Practice with the BeVigilant™ OraFusion™ System

The BeVigilant™ OraFusion™ System provides clarity to confidently assess oral cancer risks, offering peace of mind for you and your patients, and the data to act urgently when early intervention is key.

How the BeVigilant™ OraFusion™ System** Works

BeVigilant™ OraFusion™ System is an easy-to-use, accurate*, semi-quantitative tool for frontline healthcare clinicians assessing potentially at-risk patients for oral cancer.
The BeVigilant™ Reader is an advanced immunochromatography reader which captures the test data and provides the results during the patient’s visit.

Created to improve outcomes through earlier intervention, the BeVigilant™ OraFusion™ System** is

Check Mark Icon


Using multiple biomarkers in conjunction with clinical risk factors provides an accurate risk assessment

Check Mark Icon


A simple saliva test eliminates the need for invasive procedures, offering ease and convenience

Check Mark Icon


Delivering results in 15 minutes or less, streamlining next steps and treatment decisions.

The BeVigilant™ OraFusion™ System is patent pending and available in select markets outside the United States. 

Schedule a demo to discover if the BeVigilant OraFusion System is right for your practice.

*Clinical Data on File